Talking Points

C. Michael Gibson talks with Patrick Serruys about, TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population."

C. Michael Gibson and Hiroki Shiomi look at long-term outcomes from RESET.

C. Michael Gibson and Lars Sondergaard discuss 1-year outcomes in the PORTICO I trial.

Does timing of an atorvastatin loading dose make a difference in PCI for ACS? C. Michael Gibson and Renato Lopes discuss.

C. Michael Gibson, Kenneth Rosenfield, and Robert Lookstein discuss the way forward for PERT.

C. Michael Gibson and Jörg Hausleiter discuss the TRIVALVE trial.

C. Michael Gibson and Clemens von Birgelen discuss the BIONYX randomized trial.

C. Michael Gibson and Pieter Stella discuss ReCre8, which evaluated a polymer-free DES in an all-comers population.

What do you get when you combine Twitter and a textbook? C. Michael Gibson talks with Michael Savage and David Fischman.

C. Michael Gibson talks to William Gray about IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions.

C. Michael Gibson speaks with Dominick Angiolillo about the 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI.

Early results with a new device being developed for transcatheter MV replacement are promising, Paul Sorajja tells C. Michael Gibson.

C. Michael Gibson gets the details from DAPT-STEMI from Elvin Kedhi.

TRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary Mitral Regurgitation

Dr. C. Michael Gibson talks to Dr. David W. M. Muller about TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Dr. C. Michael Gisbon talks to Dr. Shao-Liang Chen about the DKCRUSH-V: A Randomized Trial of Double Kissing Crush vs Provisional Stenting for Treatment of Distal Left Main Bifurcation Lesions.

C. Michael Gibson reviews new registry results with Wayne Batchelor.

Listen to C. Michael Gibson in conversation with Giora Weisz. Color: A Multicenter Registry Looking at Lipid-Rich Plaque & 2-Year Outcomes After Stenting

C. Michael Gibson discusses health-status benefits in intermediate-risk patients treated with surgical or transcatheter aortic valve replacement.

C. Michael Gibson sits down with Sean Lyden to discuss the results.